Home ›
Trademark Categories ›
Pharmaceuticals ›
2012 ›
CY ›
CYSANTE
Trademark search for:
CYSANTE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2012-07-24 — Application filed
2012-08-30 — Sn assigned for sect 66a appl from ib
2012-08-31 — Application filed
2012-09-01 — Application filed
2012-09-05 — Application filed
2012-09-26 — Assigned to examiner
2012-09-28 — Approved for pub - principal register
2012-10-17 — Notice of publication
2012-10-17 — Notification of possible opposition sent to ib
2012-10-17 — Notice of start of opposition period created, to be sent to ib
2012-11-06 — Published for opposition
2012-11-08 — Extension of time to oppose received
2012-11-19 — Notification processed by ib
2013-03-21 — Extension of time to oppose process - terminated
2013-04-30 — Registered-principal register
2013-05-30 — Grant of protection created, to be sent to ib
2013-05-31 — Final disposition recorded
2013-05-31 — Final disposition recorded
2013-06-17 — Death of international registration
2013-06-17 — Notification of effect of cancellation of intl reg mailed
2013-08-20 — Irregularity on grant of protection received from ib
2013-08-30 — Final status recorded
Owner Information
Boehringer Ingelheim International GmbH
DE
Boehringer Ingelheim International GmbH
DE
Boehringer Ingelheim International GmbH
DE
Correspondent
Boehringer Ingelheim International GmbH CDept. IPR & Trademarks Binger Strasse 173 55216 Ingelheim,
Filing Details
Filing Date:
2012-07-24
Status Date:
2013-08-30
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.